Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 18 EP applications Philip Lenaerts has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12717780

NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES

IPC classification:
A61K 31/5513, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14715255

NOVEL N-(2,3-DIHYDRO-1H-PYRROLO[2,3-B]JPYRIDIN-5-YL)-4- QUINAZOLINAMINE AND N-(2,3-DIHYDRO-1H-INDOL-5-YL)-4- QUINAZOLINAMINE DERIVATIVES AS PERK INHIBITORS

IPC classification:
C07D 405/14, A61P 35/00, A61K 31/517, C07D 471/04, C07D 409/14, C07D 403/14, C07D 413/14, C07D 403/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14719024

3-(2-AMINOPYRIMIDIN-4-YL)-5-(3-HYDROXYPROPYNYL)-1H-PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS NIK INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP14776635

NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS

IPC classification:
A61K 31/505, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14772372

NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2c]PYRIDINE DERIVATIVES AS NIK INHIBITORS

IPC classification:
A61P 35/00, A61K 31/506, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP15713523

MACROCYLIC PYRIDINE DERIVATIVES

IPC classification:
A61P 35/00, A61K 31/505, C07D 498/22, C07D 471/22
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP15712138

SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND 2,3-DIHYDRO-1H-IMIDAZO[1,2-B]PYRAZOLE DERIVATIVES AS ROS1 INHIBITORS

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15713522

MACROCYLIC PYRIMIDINE DERIVATIVES

IPC classification:
A61P 35/00, A61K 31/505, C07D 498/22, C07D 471/22
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15713436

SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-A][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS

IPC classification:
A61K 35/00, A61K 31/519, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15787932

NEW COMPOUNDS AS NIK INHIBITORS

IPC classification:
A61P 35/00, A61K 31/505, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15784050

NEW PYRAZOLOPYRIMIDINE DERIVATIVES AS NIK INHIBITORS

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15787516

NEW THIENOPYRIMIDINE DERIVATIVES AS NIK INHIBITORS

IPC classification:
A61P 35/00, A61K 45/06, C07D 519/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15784360

NEW PYRAZOLE DERIVATIVES AS NIK INHIBITORS

IPC classification:
A61P 35/00, A61K 31/4155, C07D 417/14, C07D 407/14, C07D 403/14, C07D 403/04, C07D 413/14, C07D 401/14
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15816165

HETEROCYCLYL LINKED IMIDAZOPYRIDAZINE DERIVATIVES AS PI3KBETA INHIBITORS

IPC classification:
C07D 487/04, A61K 31/541, A61K 31/5355, C07D 405/10
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15810784

IMIDAZOPYRIDAZINE DERIVATIVES AS 3 INHIBITORS

IPC classification:
A61P 35/00, A61K 31/5025, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16197293

COMBINATIONS OF A TELOMERASE INHIBITOR AND A BCL-2 INHIBITOR FOR THE TREATMENT OF HEMATOLOGICAL CANCERS

IPC classification:
A61P 35/02, A61P 35/00, A61K 31/7125, A61K 31/635, A61K 45/06
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
The application has been published
EP16757233

NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS

IPC classification:
A61K 31/53, A61K 31/519, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP16778024

QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KBETA INHIBITORS

IPC classification:
A61K 31/4985, A61K 31/498, A61K 31/4025, A61K 31/397, C07D 513/10, C07D 498/10, C07D 491/10, C07D 487/02, C07D 471/04, C07D 417/06, C07D 241/14, C07D 413/06, C07D 413/04, C07D 403/14, C07D 403/06, C07D 403/04, C07D 401/06, C07D 401/04, C07D 403/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Philip Lenaerts, Janssen Pharmaceutica N.V.
Status:
Request for examination was made

Please Sign in to use this feature